Codex DNA Inc (DNAY) News

Codex DNA to Present at the Jefferies London Healthcare Conference

SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop...

Current Report Filing (8-k)

0001850079false00018500792021-11-082021-11-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Codex DNA Reports Third Quarter 2021 Financial Results

SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop...

Codex DNA to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021

SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop...

Current Report Filing (8-k)

0001850079false00018500792021-09-162021-09-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Codex DNA Reports Second Quarter 2021 Financial Results

SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop...

Codex DNA Announces Synthetic Biology Collaboration with U.S. Department of Agriculture to Combat Citrus Greening Disease

SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop...

Codex DNA to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021

SAN DIEGO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), the pioneer in automated...

Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap® mRNA Capping Technology

SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Sec Staff Action/letter (sec Staff)

Codex DNA Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional...

SAN DIEGO, June 22, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY) today announced the closing of...

Codex DNA Announces Pricing of Initial Public Offering

SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (“Codex DNA”), creators of the BioXp™ system, a...